1. Market Research
  2. > Pharmaceutical Market Trends
Protein Binding Assay Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology ; End User, and Geography.

Protein Binding Assay Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology ; End User, and Geography.

  • August 2021
  • 145 pages
  • ID: 6154062
  • Format: PDF
  • The Insight Partners

Summary

Table of Contents

Search Inside

The protein binding assay market is expected to reach US$ 694.63 million by 2028 from US$ 340.14 million in 2021; it is estimated to grow at a CAGR of 10.7% from 2021 to 2028. Surge in drug discovery activities and growing need to reduce the costs of drug discovery and development are among key factors driving the market growth. However, challenges associated with the existing technologies hinder the market growth. Protein binding assays assist in analyzing the interaction between two types of proteins. These assays are widely used in the new drug development process.

A clinical trial is a crucial and significant step in the determination of the safety and effectiveness of a medical strategy, treatment, and device for commercial usage.These studies also help understand and determine the best medical approaches for a particular therapeutic area.

Before the approval of drug molecules or medical devices by the regulatory authorities, a series of clinical studies are conducted.The increasing prevalence of communicable and non-communicable diseases is triggering the demand for the development of new drugs and medical devices, which, in turn, propels the demand for the protein binding assay.

As per the data from the US National Library of Medicine, in 2018, there were ~280,801 clinical studies ongoing in 50 states and 204 countries. The following figure shows the rise in the number of studies registered in period of year 2015 to 2020.

Table 1. Number of Registered Studies for Clinical Trials
Year First Posted Studies at Start of Year Studies During Year Studies at End of Year
2015 181,304 24,130 205,434
2016 205,434 27,809 233,243
2017 233,243 29,198 262,441
2018 262,441 17,836 280,277
2019 293,275 32,519 325,794
2020 325,794 36,740 362,534
Source: Clinical Trials.gov and the Insight Partners Analysis

Furthermore, pharmaceutical, medical device, and biotechnology companies focus on research and development (R&D) activities to develop new molecules for therapeutic applications with the greatest medical and commercial potential. The companies invest majorly in the R&Ds intending to deliver high quality and innovative products to the market.

Table 2. Top 10 Pharmaceutical R&D Spenders, 2019
Name of Company (R&D Budget as % of Revenue) Name of Company (R&D Budget as % of Revenue)
1. F. Hoffmann La-Roche Ltd. (19.0%) 2. Johnson & Johnson Services, Inc. (13.8%)
3. Merck KGaA (21.1%) 4. Novartis AG (19.8%)
5. Pfizer, Inc. (16.7%) 6. Sanofi S.A (16.7%)
7. AbbVie, Inc. (19.0%) 8. Bristol Myers Squibb Company Limited (23.6%)
9. AstraZeneca Plc. (24.8%) 10. GlaxoSmithKline Plc (13.8%)
Source: PhRMA, The Insight Partner’s Analysis

In the early stages of the drug development process, protein binding assays are being developed.Because unbound circulating drugs have the best access to targets and excretion pathways, drug candidate binding to plasma proteins is crucial for drug distribution, efficacy, and safety margin definition.

According to Statista, around 7,493 drugs entered the preclinical stage in 2017, and the number is estimated to reach 8,040 in 2018.As a result, the total number of drug candidates being screened each year is increasing.

Protein binding studies, which are conducted early in the drug development process, are an important aspect of the preclinical phase. Hence, the rising drug discovery activities coupled with increasing pharmaceutical R&D expenditure drives the growth of the protein binding assay market.

Technology Insights
Based on technology, the global protein binding assay market is segmented into ultracentrifugation ultrafiltration, equilibrium dialysis, surface plasmon, and others.In 2020, the equilibrium dialysis segment held the largest share of the market.

However, the ultrafiltration segment is expected to register the highest CAGR in the market during 2021-2028.Equilibrium dialysis is among the most widely accepted methods for evaluating protein binding, and it can be performed with the help of rapid equilibrium dialysis (RED) devices.

Researchers prefer this method as it has fewer binding effects to extraneous and unintended factors affecting research results.

End User Insights
Based on end user, the protein binding assay market is segmented into contract research organization, pharmaceutical and biotechnology companies, and research and diagnostic laboratories.The pharmaceutical and biotechnology companies segment is expected to hold the largest market share in 2021.

It is also expected to be the largest shareholder in the market by 2028.These companies are the major adopters of CRO services; they approach CROs for outsourcing drug and molecule research and development.

Protein binding is a fundamental biochemical process that is used to study the mechanism of drugs along with their pharmacological effects in subjects. These aspects are propelling the protein binding assay market for the market for the pharmaceutical and biotechnology companies segment.

A few major primary and secondary sources referred to while preparing the report on the global protein binding assay market are European Federation of pharmaceutical Industries and Associations (EFPIA), National Institute for Health Research (NHS), International Trade Administration (ITA), Spanish Council of Ministers established an Ethics Committees for Investigation (CEIm), Spanish Clinical Studies Registry (REec), Spanish Agency of Medicines and Medical Devices (AEMPS), KoNECT Collaboration Center (Korea National Enterprise for Clinical Trials), International Organization for Standardization (ISO), Medical Research Future Fund (MRFF), Ministry of Health (MOH), Health Sciences Authority (HSA), Argentine Ministry of Health (ANMAT), and European Centre for Disease Prevention and Control (ECDC).

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Organ-On-Chip (OOC) Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery

  • $ 5000
  • October 2021
  • 143 pages

Organ-On-Chip (OOC) Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to ...

  • World
  • Pharmaceutical
  • Drug Development
  • Industry analysis
  • Health Expenditure
  • Drug Approval

ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on